Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
Denali Capital Acquisition Corp. (NASDAQ: DECA) and Longevity Biomedical, Inc. have mutually decided to terminate their previously announced business combination agreement. This decision, announced on June 27, 2024, reflects a strategic shift for both parties. Denali, along with its sponsor, is now focusing on exploring alternative avenues to complete an initial business combination.
- None.
- None.
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or the "Company") announced today that Denali and Longevity Biomedical, Inc. have mutually agreed to terminate their previously announced business combination agreement (the “Business Combination Agreement”). The Company and its sponsor intend to seek alternative ways to consummate an initial business combination.
About Denali Capital Acquisition Corp.
Denali Capital Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
Forward-Looking Statements
This press release includes forward looking statements that involve risks and uncertainties. Forward looking statements are subject to numerous conditions, risks and changes in circumstances, many of which are beyond the control of the Company, including those set forth in the "Risk Factors" section of the Company's prospectus for its initial public offering filed with the SEC. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
Contact:
Carley Wan
646-978-5001
FAQ
Why did Denali Capital Acquisition Corp. (DECA) and Longevity Biomedical, Inc. terminate their business combination?
What is the current status of Denali Capital Acquisition Corp.'s (DECA) business combination plans?
When was the termination of the business combination between Denali Capital Acquisition Corp. (DECA) and Longevity Biomedical, Inc. announced?
What is the stock symbol for Denali Capital Acquisition Corp.?
Is Denali Capital Acquisition Corp. (DECA) planning to find a new business combination partner?
